The Recall Desk
Our severity:HighCPSC·19742·Announced 2019-04-25

TriDerma Recalls Pain Relief Cream for Child-Resistant Packaging Failure

TriDerma is recalling Pain Relief Cream with Lidocaine because the packaging fails to meet child-resistant closure requirements, posing a poisoning risk to young children.

What this means for you

Our assessment, not the agency’s: severity 3/5 (High).

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a risk-of-harm product (poisoning via lidocaine ingestion) where injury has not yet been reported, which aligns with the 'High' severity criteria in the rubric.

Plain-English summary

TriDerma, of Corona, Calif., is recalling approximately 410 units of Pain Relief Cream with 4% Lidocaine. The recall involves the product in a 4-ounce jar and a 2.2-ounce tube. The affected products were sold online at www.triderma.com from January 2018 through April 2019 for approximately $22 for the jar and $15 for the tube.

The recall is due to the packaging's failure to meet the child-resistant closure requirements of the Poison Prevention Packaging Act. Because the cream contains lidocaine, it poses a risk of poisoning to young children if they apply it to their skin or ingest it. No injuries have been reported.

Consumers should immediately store the topical anesthetic in a safe location out of reach of children. They should contact TriDerma at 800-279-7282, email [email protected], or visit www.triderma.com to request a free replacement child-resistant cap. TriDerma is also contacting all known purchasers directly.

The recalled product

Product
Pain Relief Cream with Lidocaine
Manufacturer
TriDerma, of Corona, Calif.
Category
Consumer Product — Topical Anesthetic
Hazard
Affected units
410

Distribution

Distributed nationwide across the United States.

Related recalls

Same hazard · poisoning

See all →

Similar recalls